UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

European consensus table on the use of botulinum toxin type A in adult spasticity

Journal of rehabilitation medicine, 2009-01, Vol.41 (1), p.13-25

2009

Volltextzugriff (PDF)

Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study

European journal of clinical investigation, 2004-04, Vol.34 (4), p.312-313

2004

Volltextzugriff (PDF)

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression

Journal of neurology, 2002-07, Vol.249 (7), p.842-846

2002

Volltextzugriff (PDF)

A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A

Neurology, 2003-10, Vol.61 (7), p.940-944

2003

Volltextzugriff (PDF)

Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms

British journal of dermatology (1951), 1997-04, Vol.136 (4), p.548-552

1997

Volltextzugriff (PDF)

A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model

Anesthesia and analgesia, 2006-02, Vol.102 (2), p.509-516

2006

Volltextzugriff (PDF)

Novel mutations for SPG 11 in a 25-year old woman with hereditary spastic paraparesis and evidence for upper extremity involvement

Journal of the neurological sciences, 2013-10, Vol.333, p.e477-e477

2013

Volltextzugriff (PDF)

Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A

Neurology, 2008-01, Vol.70 (2), p.133-136

2008

Volltextzugriff (PDF)

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK 1 and NK 3 receptors

British journal of pharmacology, 2011-02, Vol.162 (4), p.929-946

2011

Volltextzugriff (PDF)

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK1 and NK3 receptors

British journal of pharmacology, 2011-02, Vol.162 (4), p.929-946

2011

Volltextzugriff (PDF)

Relation between depression and anxiety in dystonic patients: implications for clinical management

Depression and anxiety, 2002, Vol.16 (3), p.100-103

2002

Volltextzugriff (PDF)

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients

British journal of dermatology (1951), 2001-08, Vol.145 (2), p.289-293

2001

Volltextzugriff (PDF)

Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature

Journal of neurology, 2004-02, Vol.251 Suppl 1, p.I19-1

2004

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis

British journal of dermatology (1951), 1999-04, Vol.140 (4), p.677-680

1999

Volltextzugriff (PDF)

Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache?

Cephalalgia, 2001-07, Vol.21 (6), p.691-696

2001

Volltextzugriff (PDF)

Long-Term Outcome of Patients with Headache and Drug Abuse after Inpatient Withdrawal: Five-Year Follow-up

Cephalalgia, 1996-11, Vol.16 (7), p.481-485

1996

Volltextzugriff (PDF)

Neuropsychological, MRI and EEG findings after very mild traumatic brain injury

Brain injury, 1999, Vol.13 (10), p.821-827

1999

Volltextzugriff (PDF)

Efficacy and safety of a standardised 500 unit dose of Dysport® (Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study

Journal of neurology, 2001-12, Vol.248 (12), p.1073-1078

2001

Volltextzugriff (PDF)

Psychiatric comorbidity in patients with spasmodic torticollis

Journal of psychosomatic research, 1998-06, Vol.44 (6), p.687-690

1998

Volltextzugriff (PDF)

To do or not to do? Magnetic resonance imaging in mild traumatic brain injury

Brain injury, 2001-02, Vol.15 (2), p.107-115

2001

Volltextzugriff (PDF)

Long-term follow-up in cerebral Whipple's disease

European journal of gastroenterology & hepatology, 1996-09, Vol.8 (9), p.899

1996

Volltextzugriff (PDF)

Psychiatric disorders in patients with blepharospasm — a reactive pattern?

Journal of psychosomatic research, 2000-06, Vol.48 (6), p.589-591

2000

Volltextzugriff (PDF)

Botulinum A toxin injection in Focal hyperhidrosis

British journal of dermatology (1951), 1996-06, Vol.134 (6), p.1160-1162

1996

Volltextzugriff (PDF)

Botulinum toxin in rare pain syndromes

Journal of neurology, 2004-02, Vol.251 Suppl 1 (S1), p.I39-i40

2004

Volltextzugriff (PDF)

Dose thresholds and local anhidrotic effect of botulinum A toxin injections (Dysport®)

British journal of dermatology (1951), 2001-08, Vol.145 (2), p.368-369

2001

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(100)
Science & Technology
(92)
Life Sciences & Biomedicine
(83)
Male
(63)
Adult
(61)
Female
(57)
Biological And Medical Sciences
(51)
Medical Sciences
(48)
Middle Aged
(47)
Aged
(33)
Neurosciences & Neurology
(29)
Clinical Neurology
(27)
Neurology
(18)
Botulinum Toxins, Type A - Therapeutic Use
(16)
Neurosciences
(15)
Pharmacology. Drug Treatments
(13)
Risk Factors
(12)
Adolescent
(11)
Aged, 80 And Over
(11)
Anesthesiology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

European consensus table on the use of botulinum toxin type A in adult spasticity

Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression

A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A

Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms

A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model

Novel mutations for SPG 11 in a 25-year old woman with hereditary spastic paraparesis and evidence for upper extremity involvement

Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK 1 and NK 3 receptors

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK1 and NK3 receptors

Relation between depression and anxiety in dystonic patients: implications for clinical management

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients

Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature

A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis

Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache?

Long-Term Outcome of Patients with Headache and Drug Abuse after Inpatient Withdrawal: Five-Year Follow-up

Neuropsychological, MRI and EEG findings after very mild traumatic brain injury

Efficacy and safety of a standardised 500 unit dose of Dysport® (Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study

Psychiatric comorbidity in patients with spasmodic torticollis

To do or not to do? Magnetic resonance imaging in mild traumatic brain injury

Long-term follow-up in cerebral Whipple's disease

Psychiatric disorders in patients with blepharospasm — a reactive pattern?

Botulinum A toxin injection in Focal hyperhidrosis

Botulinum toxin in rare pain syndromes

Dose thresholds and local anhidrotic effect of botulinum A toxin injections (Dysport®)

Suchergebnisse filtern